Atlas Trials

A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003

Clinical trial NCT01725594 · COMPLETED

Trial details

NCT number
NCT01725594
Sponsor
Catabasis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2012-11-01
Primary completion
2013-05-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.